CAS: 1531589-13-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Brolucizumab REF: 3D-CLA1382CAS: 1531589-13-5 | - - - | To inquire | Tue 17 Dec 24 |
 | Brolucizumab REF: TM-T80593CAS: 1531589-13-5 | 98% | 233.00 €~2,623.00 € | Fri 07 Feb 25 |
Brolucizumab
CAS:1531589-13-5
Humanized single-chain antibody fragment targeting Vascular endothelial growth factor A (VEGFA)
Ref: 3D-CLA1382
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Brolucizumab
CAS:1531589-13-5
Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment exhibiting low picomolar affinity (K D = …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80593
| 1mg | 233.00 € | ||
| 5mg | 607.00 € | ||
| 10mg | 928.00 € | ||
| 25mg | 1,439.00 € | ||
| 50mg | 1,862.00 € | ||
| 100mg | 2,623.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
